More T Cells versus Better T Cells in Patients with Breast Cancer.

Détails

ID Serval
serval:BIB_3675736551F9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
More T Cells versus Better T Cells in Patients with Breast Cancer.
Périodique
Cancer discovery
Auteur(s)
Speiser D.E., Verdeil G.
ISSN
2159-8290 (Electronic)
ISSN-L
2159-8274
Statut éditorial
Publié
Date de publication
10/2017
Peer-reviewed
Oui
Volume
7
Numéro
10
Pages
1062-1064
Langue
anglais
Notes
Publication types: Journal Article ; Comment
Publication Status: ppublish
Résumé
<b/> Characterization of intratumoral leukocyte populations may help in estimating patients' prognosis and predictions. A new study shows remarkable differences between the <i>in situ</i> and invasive breast cancer stages and highlights that cell number analyses should be complemented with characterization of T-cell functions, increasing the likelihood that immune competent antitumor T cells and further biomarkers are identified for guiding therapy choices. <i>Cancer Discov; 7(10); 1062-4. ©2017 AACR.</i> <i>See related article by Gil Del Alcazar et al., p. 1098</i> .
Mots-clé
Biomarkers, Breast Neoplasms/immunology, Humans, Prognosis, T-Lymphocytes
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/10/2017 12:42
Dernière modification de la notice
20/08/2019 13:24
Données d'usage